Lionheart Health Inc. Newsroom

Lionheart Health, Inc. has started enrollment for its Lionheart Klotho-Up™ Study, a program to evaluate a wellness and bioelectric intervention for healthy aging. The study includes nutrition, exercise, and optional therapies to assess muscle, brain, and immune health.

Lionheart Health, Inc. announced that renowned neurosurgeon and longevity-focused brain health authority Joseph C. Maroon, MD, FACS—Clinical Professor of Neurosurgery at UPMC and longtime Team Neurosurgeon for the Pittsburgh Steelers—has joined the company’s Scientific and Clinical Advisory Board.

Lionheart Health, Inc. announces a USPTO Letter of Allowance for its patented bioelectric technology designed to upregulate GDF10 and complementary regenerative proteins, supporting investigational applications in brain health, stroke recovery, muscle function, liver resilience, and systemic healthspan optimization.

At Lionheart Health, our mission is to translate rigorous science into practical, clinician-guided solutions that help people function better today while protecting their long-term health,” said Leslie Miller, Chief Medical Officer of Lionheart Health, Inc.

Lionheart Health launched its Health Optimization Membership Program delivering a 461-biomarker test, clinician consultation, personalized klotho-focused protocol, discounts on 200+ products, and priority entry into the Lionheart Klotho-Up™ Study competing in the XPRIZE Healthspan competition.

Rejuvant’s CaAKG Supplement Becomes Core Requirement in Lionheart’s KLOTHO-UP™ Study and Klotho Wellness Program

New intellectual property spans oral, topical, and injectable peptides, with a focus on improving the efficiency of Klotho-based longevity interventions.

The newly filed patent protects a transformative therapeutic system that combines nanoflower-format nanoparticles, bioelectric signaling sequences, and Klotho-modulating biologics to target the cellular and mitochondrial drivers of aging.

The inaugural Klotho Conference & Scientific Seminar, held September 15–16 at the UCI Beall Applied Innovation Center, brought together leading researchers, clinicians, and innovators.

Designed to control regenerative protein expressions in vessel walls and surrounding tissues for a wide range of applications.